Location History:
- Wolfratshausen, DE (2003)
- Gelting, DE (2005)
Company Filing History:
Years Active: 2003-2005
Title: Sebastian Meier-Ewert: Innovator in Molecular Interaction Identification
Introduction
Sebastian Meier-Ewert is a notable inventor based in Gelting, Germany. He has made significant contributions to the field of molecular biology through his innovative methods for identifying and characterizing interacting molecules. With a total of 2 patents, his work has the potential to impact pharmaceutical development significantly.
Latest Patents
Sebastian's latest patents include a method for the identification and characterization of interacting molecules by automated interaction mating. This invention relates to an improved method designed to detect positive clones from the large numbers of false positive clones isolated by conventional two-hybrid systems. The method relies on a novel combination of selection steps to accurately identify clones that express interacting molecules. This invention provides high-throughput interaction screens for reliable identification, which can lead to the discovery of substances that inhibit these interactions. Such inhibitors can be utilized in formulating pharmaceutical compositions. Additionally, he has developed a kit useful for carrying out this method.
Career Highlights
Sebastian Meier-Ewert is associated with the Max Planck Society for the Advancement of Science, where he continues to contribute to research and innovation in molecular interactions. His work is characterized by a commitment to improving existing methodologies and enhancing the reliability of molecular identification processes.
Collaborations
Sebastian has collaborated with notable colleagues, including Erich Wanker and David Bancroft, to further advance research in this field. Their combined expertise has led to significant advancements in understanding molecular interactions.
Conclusion
Sebastian Meier-Ewert's innovative approaches to identifying and characterizing interacting molecules position him as a key figure in molecular biology. His contributions have the potential to influence pharmaceutical development and enhance our understanding of molecular interactions.